Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
Progyny (Nasdaq: PGNY) has appointed Debra Morris, a 30-year healthcare industry veteran, to its board of directors effective January 16, 2025. Morris, who currently serves as President of AccessHope, brings extensive experience in healthcare operations and financial management. She previously held the position of EVP and CFO at Apria Healthcare.
Morris will serve on the Compensation Committee and brings personal experience with infertility along with professional expertise in scaling organizations, healthcare systems, payment models, and operational efficiency. CEO Pete Anevski highlighted Morris's ability to navigate periods of rapid growth as particularly valuable for Progyny's continued expansion of family building and women's healthcare solutions.
Progyny (Nasdaq: PGNY) ha nominato Debra Morris, veterana dell'industria sanitaria con 30 anni di esperienza, nel suo consiglio di amministrazione a partire dal 16 gennaio 2025. Morris, attualmente Presidente di AccessHope, porta con sé una vasta esperienza in operazioni sanitarie e gestione finanziaria. In precedenza ha ricoperto il ruolo di EVP e CFO presso Apria Healthcare.
Morris farà parte del Comitato per le Compensazioni e aggiunge un'esperienza personale con l'infertilità, unita a competenze professionali nella scalabilità delle organizzazioni, sistemi sanitari, modelli di pagamento e efficienza operativa. Il CEO Pete Anevski ha sottolineato come la capacità di Morris di gestire periodi di rapida crescita sia particolarmente preziosa per l'espansione continua delle soluzioni di costruzione familiare e assistenza sanitaria femminile di Progyny.
Progyny (Nasdaq: PGNY) ha nombrado a Debra Morris, una veterana de la industria de la salud con 30 años de experiencia, para su junta directiva, con efecto a partir del 16 de enero de 2025. Morris, quien actualmente es Presidenta de AccessHope, aporta una amplia experiencia en operaciones de salud y gestión financiera. Anteriormente ocupó el cargo de EVP y CFO en Apria Healthcare.
Morris formará parte del Comité de Compensación y aporta una experiencia personal con la infertilidad, junto con experiencia profesional en la escalabilidad de organizaciones, sistemas de salud, modelos de pago y eficiencia operativa. El CEO Pete Anevski destacó la capacidad de Morris para navegar en períodos de rápido crecimiento como especialmente valiosa para la continua expansión de Progyny en las soluciones de construcción familiar y atención sanitaria para mujeres.
Progyny (Nasdaq: PGNY)는 Debra Morris를 이사회에 임명했습니다. Morris는 30년간의 의료 산업 경험을 가진 베테랑으로, 2025년 1월 16일부터 발효됩니다. 현재 AccessHope의 회장으로 재직 중인 Morris는 의료 운영 및 재무 관리에 대한 광범위한 경험을 제공합니다. 그녀는 이전에 Apria Healthcare에서 EVP 및 CFO라는 직책을 맡았습니다.
Morris는 보상위원회에서 활동하며 불임에 대한 개인적 경험과 조직의 규모 확장, 의료 시스템, 지불 모델 및 운영 효율성에 대한 전문성을 가지고 있습니다. CEO Pete Anevski는 Progyny의 가족 구성 및 여성 건강 솔루션의 지속적인 확장을 위해 Morris의 빠른 성장 시기를 탐색하는 능력이 특히 가치 있다고 강조했습니다.
Progyny (Nasdaq: PGNY) a nommé Debra Morris, vétérane de 30 ans de l'industrie de la santé, au conseil d'administration, avec effet à partir du 16 janvier 2025. Morris, qui est actuellement présidente d'AccessHope, apporte une vaste expérience dans les opérations de santé et la gestion financière. Auparavant, elle a occupé le poste de EVP et CFO chez Apria Healthcare.
Morris siègera au Comité de Compensation et apporte une expérience personnelle avec l'infertilité ainsi qu'une expertise professionnelle dans l'évolutivité des organisations, des systèmes de santé, des modèles de paiement et l'efficacité opérationnelle. Le PDG Pete Anevski a souligné que la capacité de Morris à naviguer pendant des périodes de croissance rapide est particulièrement précieuse pour l'expansion continue de Progyny dans les solutions de création de famille et de santé des femmes.
Progyny (Nasdaq: PGNY) hat Debra Morris mit 30 Jahren Erfahrung in der Gesundheitsindustrie in seinen Vorstand berufen, der am 16. Januar 2025 in Kraft tritt. Morris, die derzeit Präsidentin von AccessHope ist, bringt umfangreiche Erfahrungen in den Bereichen Gesundheitsoperationen und Finanzmanagement mit. Zuvor war sie EVP und CFO bei Apria Healthcare.
Morris wird im Vergütungsausschuss tätig sein und bringt persönliche Erfahrungen mit Unfruchtbarkeit sowie professionelle Expertise in der Skalierung von Organisationen, Gesundheitssystemen, Zahlungsmodellen und operationeller Effizienz mit. CEO Pete Anevski hob hervor, dass Morris’ Fähigkeit, Phasen schneller Wachstums zu bewältigen, für die fortlaufende Expansion von Progyny im Bereich Familienbildung und Frauengesundheitslösungen besonders wertvoll ist.
- Appointment of seasoned healthcare executive with 30 years of industry experience
- Addition of expertise in scaling operations and healthcare payment models
- Board member brings direct experience with company's core service (infertility)
- None.
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women’s health benefits solution, today announced the appointment of 30-year healthcare industry veteran Debra Morris to its board of directors, effective January 16, 2025.
Debra Morris currently serves as President of AccessHope, a company changing the way leading-edge cancer expertise is delivered. Previously she served as EVP and CFO of Apria Healthcare where she demonstrated her ability to navigate complex industry challenges, drive operational excellence, and deliver value to stakeholders. With her extensive board service and proven leadership in handling periods of rapid industry change, Morris is well-positioned to positively impact Progyny as it continues to transform fertility, family building, and women’s healthcare.
“Debby’s ability to scale organizations and her expertise in our healthcare system and payment models, operational efficiency, and navigating periods of rapid growth make her a perfect addition to Progyny,” said Pete Anevski, Chief Executive Officer, Progyny. “Her extensive experience will be invaluable as we continue to expand access to our industry-leading family building and women’s healthcare solutions.”
“As someone who personally experienced the challenges of infertility, I’m excited to bring my professional and personal experience to support such an important mission,” said Morris. “Progyny’s innovative model, superior outcomes, and commitment to empowering women and families set it apart as a true leader in the space.”
Morris will serve on the Compensation Committee.
For more information visit www.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When does Debra Morris join Progyny's (PGNY) board of directors?
What is Debra Morris's current role outside of Progyny (PGNY)?
Which committee will Debra Morris serve on at Progyny (PGNY)?
What is Debra Morris's previous executive experience before joining Progyny's (PGNY) board?
How does Debra Morris's experience align with Progyny's (PGNY) business?
